Regulatory T‐cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer

Author:

Suzuki Susumu12ORCID,Tsuzuki Toyonori3ORCID,Saito Masato4,Ishii Toshihiko5,Takahara Taishi3ORCID,Satou Akira3,Inukai Daisuke6,Yamanaka Shunpei6,Yoshikawa Kazuhiro1,Ueda Ryuzo27,Ogawa Tetsuya6

Affiliation:

1. Research Creation Support Center Aichi Medical University Nagakute Japan

2. Department of Tumor Immunology Aichi Medical University School of Medicine Nagakute Japan

3. Department of Surgical Pathology Aichi Medical University Hospital Nagakute Japan

4. Translational Research Unit R&D Division, Kyowa Kirin Tokyo Japan

5. Research Unit, R&D Division, Kyowa Kirin Shizuoka Japan

6. Department of Otorhinolaryngology Aichi Medical University School of Medicine Nagakute Japan

7. Department of Immunology Nagoya University Graduate School of Medicine Nagoya Japan

Abstract

AbstractRegulatory T cells (Tregs) play an important role in creating an immunosuppressive microenvironment in cancer tissues. However, the mechanisms by which Tregs are activated and suppress cancer immunity remain unclear. To elucidate these mechanisms, we performed a T cell receptor (TCR) repertoire analysis of Tregs and conventional T cells in peripheral blood, draining lymph nodes (DLNs), and cancer tissues of patients with head and neck squamous cell cancer (HNSCC). We found that the TCR repertoire was skewed in cancer tissue and metastatic DLNs (M‐DLNs) compared with non‐metastatic DLNs, and TCR repertoire similarities in Tregs and CD8+ T cells between M‐DLNs and cancer tissue were high compared with those at other sites. These results suggest that Tregs and CD8+ T cells are activated in M‐DLNs and cancer tissues by cancer antigens, such as neoantigens, and shared antigens and Tregs suppress CD8+ T cell function in a cancer antigen‐specific manner in M‐DLNs and cancer tissue. Moreover, M‐DLNs might be a source of Tregs and CD8+ T cells recruited into the cancer tissue. Therefore, targeting Tregs in M‐DLNs in an antigen‐specific manner is expected to be a novel immunotherapeutic strategy for HNSCCs.

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3